Selective publication of positive trials on antidepressants

January 7, 2008- Interviewed and produced by Steven Greer, MD

Erick Turner, MD, psychiatrist at Oregon Health and Science University and former FDA medical officer reviewing psychotropic drugs, discusses his new England Journal of Medicine paper on the problem of selectively publishing only the positive trials on antidepressants and the failure of drug companies to publish the negative trials, thus skewing the body of literature.

This entry was posted in Oregon Health and Science University, Psychology Psychiatry. Bookmark the permalink.

Leave a Reply